XG
XGN
EXAGEN INC.
$4.67
+4.24%
$112.8M
No data for this timeframe.
Vol
Market Cap$112.8M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (91%)
Inst. Holders26 funds
Inst. Value$12.1M
Inst. Activity3 buys / 5 sells
Insider Activity0B / 3S
Insider Net $-$103.8K
SEC Reports7
Press Releases1
Recent Activity
May 27, 2026
short_volume
Short Volume: XGN — 61.6% short (0.3M / 0.5M)
Short: 329,404 | Exempt: 0 | TRF Vol: 534,594 | Short Ratio: 61.6% | Off-exchange volume (dark pool
May 11, 2026
SEC
Exagen reported Q1 2026 revenue of $17.3M, a 12% YoY increase and above the $16.4M consensus, with GAAP EPS of -$0.17 be
8-K — Impact 6/10
May 11, 2026
SEC
Exagen reported Q1 2026 revenue of $17.3M (+12% YoY) and GAAP EPS of -$0.17, beating consensus estimates of $16.4M and -
PRESS-RELEASE — Impact 7/10
Apr 23, 2026
SEC
Ana Hooker resigned from Exagen Inc.'s Board of Directors, including her role as chair of the Nominating and Corporate G
8-K — Impact 3/10
Mar 12, 2026
Insider
ABALLI JOHN was granted 100,000 shares
President and CEO @ $3.16 ($316.0K)
Mar 12, 2026
Insider
Black Jeffrey G. was granted 50,000 shares
Chief Financial Officer @ $3.16 ($158.0K)
Mar 12, 2026
Insider
Black Jeffrey G. was granted 75,000 shares
Chief Financial Officer @ $3.16 ($237.0K)
Inst.
RTW INVESTMENTS, LP — TRIM
395,231 shares ($1.2M)
Price Targets
$8.67
+85.6% upside
Strong Buy
Current $4.67
Low $8.00
Median $8.00
High $10.00
6 analysts
$8.00
$10.00
Analyst Ratings
3Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 12, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| Mar 11, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| Mar 11, 2026 | Craig-Hallum | MAINTAIN | Buy → Buy |
| Mar 11, 2026 | Keybanc | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.19 ▲ +5.0% | $-0.19 — $-0.19 | -8% YoY | 1 |
| Next Q | $-0.14 ▲ +17.6% | $-0.14 — $-0.14 | 55% YoY | 1 |
| Current FY | $-0.65 ▲ +18.8% | $-0.67 — $-0.63 | 23% YoY | 2 |
| Next FY | $-0.43 ▼ -38.7% | $-0.45 — $-0.41 | 34% YoY | 2 |
Latest Reports
BULLISH
8-K
6/10
Exagen reported Q1 2026 revenue of $17.3M, a 12% YoY increase and above the $16.4M consensus, with GAAP EPS of -$0.17 be
May 11, 2026
BULLISH
PRESS-RELEASE
7/10
Exagen reported Q1 2026 revenue of $17.3M (+12% YoY) and GAAP EPS of -$0.17, beating consensus estimates of $16.4M and -
May 11, 2026
MIXED
Press
6/10
Exagen reported record full-year 2025 revenue of $66.6 million, up 20% year-over-year, driven by 11% test volume growth
Mar 10, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | $2.4M | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.0M | — |
| SILVERCREST ASSET MANAGEMENT GROUP | $1.6M | TRIM |
| RTW INVESTMENTS, LP | $1.2M | TRIM |
| SEI INVESTMENTS CO | $732.7K | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 12, 2026 | ABALLI JOHN | A | $316.0K |
| Mar 12, 2026 | Black Jeffrey | A | $158.0K |
| Mar 12, 2026 | Black Jeffrey | A | $237.0K |
| Mar 12, 2026 | ABALLI JOHN | A | $0.00 |
| Mar 3, 2026 | ABALLI JOHN | SELL | $56.8K |
26 institutional holders with $12.1M total value (4,030,567 shares) as of 2026-Q1. Top holders: BALYASNY, VANGUARD, SILVERCREST. Net selling activity: 5 institutions trimmed/exited vs 3 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BALYASNY ASSET MANAGEMENT L.P. | 796,632 | $2.4M | 19.8% | ADD +27.1% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 678,652 | $2.0M | 16.8% | — |
| 3 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 537,870 | $1.6M | 13.3% | TRIM -50.4% |
| 4 | RTW INVESTMENTS, LP | 395,231 | $1.2M | 9.8% | TRIM -50.0% |
| 5 | SEI INVESTMENTS CO | 244,240 | $732.7K | 6.1% | DOUBLED +107.0% |
| 6 | CITADEL ADVISORS LLC | 231,115 | $693.3K | 5.7% | — |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 203,272 | $609.8K | 5.0% | ADD +47.3% |
| 8 | TWO SIGMA INVESTMENTS, LP | 157,821 | $473.5K | 3.9% | ADD +54.7% |
| 9 | BlackRock, Inc. | 125,886 | $377.7K | 3.1% | ADD +57.4% |
| 10 | First Eagle Investment Management, LLC | 125,242 | $375.7K | 3.1% | — |
| 11 | GOLDMAN SACHS GROUP INC | 121,434 | $364.3K | 3.0% | — |
| 12 | VANGUARD FIDUCIARY TRUST CO | 97,299 | $291.9K | 2.4% | — |
| 13 | STATE STREET CORP | 71,256 | $213.8K | 1.8% | ADD +68.6% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 62,571 | $187.6K | 1.6% | DOUBLED +137.4% |
| 15 | D. E. Shaw & Co., Inc. | 34,569 | $103.7K | 0.9% | — |
| 16 | Trexquant Investment LP | 33,394 | $100.2K | 0.8% | TRIM -39.9% |
| 17 | MARSHALL WACE, LLP | 27,289 | $81.9K | 0.7% | NEAR_EXIT -88.8% |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 25,476 | $76.4K | 0.6% | — |
| 19 | BARCLAYS PLC | 21,227 | $63.7K | 0.5% | ADD +48.4% |
| 20 | Point72 Asset Management, L.P. | 19,436 | $58.3K | 0.5% | NEAR_EXIT -90.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | TRIM | 790,462 | 395,231 | -50.0% | $1.2M | 2026-Q1 |
| SEI INVESTMENTS CO | DOUBLED | 118,005 | 244,240 | +107.0% | $732.7K | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 138,000 | 203,272 | +47.3% | $609.8K | 2026-Q1 |
| DIMENSIONAL FUND ADVISORS LP | DOUBLED | 26,358 | 62,571 | +137.4% | $187.6K | 2026-Q1 |
| Trexquant Investment LP | TRIM | 55,609 | 33,394 | -39.9% | $100.2K | 2026-Q1 |
| MARSHALL WACE, LLP | NEAR_EXIT | 243,424 | 27,289 | -88.8% | $81.9K | 2026-Q1 |
| Point72 Asset Management, L.P. | NEAR_EXIT | 205,200 | 19,436 | -90.5% | $58.3K | 2026-Q1 |
| MORGAN STANLEY | NEAR_EXIT | 97,438 | 12,217 | -87.5% | $36.7K | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | 723,428 | 919,187 | +27.1% | $5.6M | 2025-Q4 |
| RTW INVESTMENTS, LP | TRIM | 1,696,866 | 790,462 | -53.4% | $4.8M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 237,979 | 368,250 | +54.7% | $2.2M | 2025-Q4 |
| MARSHALL WACE, LLP | DOUBLED | 24,632 | 243,424 | +888.2% | $1.5M | 2025-Q4 |
| AMERIPRISE FINANCIAL INC | ADD | 128,348 | 192,419 | +49.9% | $1.2M | 2025-Q4 |
| BlackRock, Inc. | ADD | 82,367 | 129,613 | +57.4% | $788.0K | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 43,077 | 97,438 | +126.2% | $592.4K | 2025-Q4 |
| Trexquant Investment LP | DOUBLED | 11,105 | 55,609 | +400.8% | $338.1K | 2025-Q4 |
| ExodusPoint Capital Management, LP | DOUBLED | 10,284 | 39,321 | +282.4% | $239.1K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 55,553 | 17,601 | -68.3% | $107.0K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 63,000 | 237,979 | +277.7% | $2.6M | 2025-Q3 |
| AMERIPRISE FINANCIAL INC | ADD | 94,953 | 128,348 | +35.2% | $1.4M | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 446,207 | 90,011 | -79.8% | $989.2K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 4,214 | 55,553 | +1218.3% | $610.5K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 524,996 | 43,077 | -91.8% | $473.4K | 2025-Q3 |
| TORONTO DOMINION BANK | NEAR_EXIT | 851,289 | 20,029 | -97.6% | $220.1K | 2025-Q3 |
| BARCLAYS PLC | ADD | 5,145 | 7,636 | +48.4% | $83.9K | 2025-Q3 |
2 unique insiders with 8 transactions. Net insider value: -$103.8K ($0.00 bought, $103.8K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | ABALLI JOHN | President and CEO | AWARD | 100,000 | $3.16 | $316.0K |
| Mar 12, 2026 | Black Jeffrey G. | Chief Financial Officer | AWARD | 50,000 | $3.16 | $158.0K |
| Mar 12, 2026 | Black Jeffrey G. | Chief Financial Officer | AWARD | 75,000 | $3.16 | $237.0K |
| Mar 12, 2026 | ABALLI JOHN | President and CEO | AWARD | 150,000 | — | — |
| Mar 3, 2026 | ABALLI JOHN | President and CEO | SELL | 15,698 | $3.62 | $56.8K |
| Feb 27, 2026 | Black Jeffrey G. | Chief Financial Officer | AWARD | 1,511 | $3.08 | $4.6K |
| Feb 24, 2026 | ABALLI JOHN | President and CEO | SELL | 11,430 | $3.61 | $41.3K |
| Feb 24, 2026 | Black Jeffrey G. | Chief Financial Officer | SELL | 1,584 | $3.61 | $5.7K |
7 SEC filing reports analyzed. Sentiment: 2 bullish, 4 bearish, 0 mixed, 1 neutral. Avg impact: 5.3/10.
BULLISH
8-K
6/10
Exagen reported Q1 2026 revenue of $17.3M, a 12% YoY increase and above the $16.4M consensus, with G
May 11, 2026
BULLISH
PRESS-RELEASE
7/10
Exagen reported Q1 2026 revenue of $17.3M (+12% YoY) and GAAP EPS of -$0.17, beating consensus estim
May 11, 2026
NEUTRAL
8-K
3/10
Ana Hooker resigned from Exagen Inc.'s Board of Directors, including her role as chair of the Nomina
Apr 23, 2026
BEARISH
CLUSTER
5/10
Exagen Inc. CEO John Aballi sold nearly $57K worth of shares in an open-market transaction. This is
Mar 4, 2026
BEARISH
CLUSTER
5/10
Two corporate insiders at Exagen Inc. (XGN) sold shares in a coordinated 7-day window, including CEO
Feb 26, 2026
BEARISH
CLUSTER
5/10
Two corporate insiders at Exagen Inc. (XGN) — the CEO and CFO — sold shares in a coordinated open-ma
Feb 26, 2026
BEARISH
CLUSTER
6/10
Exagen Inc. (XGN) saw both its CEO and CFO sell shares in the open market on the same day, totaling
Feb 26, 2026
Current analyst consensus: Strong Buy (91% buy). Based on 11 analysts: 3 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$8.67 mean target
+85.6% upside
Strong Buy (3.00)
$8.00 Low
$10.00 High
| Metric | Value |
|---|---|
| Current Price | $4.67 |
| Target Low | $8.00 |
| Target Mean | $8.67 |
| Target Median | $8.00 |
| Target High | $10.00 |
| # Analysts | 6 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.19 | $-0.19 | $-0.19 | -8.1% | +5.0% | 1↑ 0↓ | $0.0B | 3.4% | 1 |
| Next Q 2026-09-30 |
$-0.14 | $-0.14 | $-0.14 | 54.8% | +17.6% | 1↑ 0↓ | $0.0B | 6.6% | 1 |
| Current FY 2026-12-31 |
$-0.65 | $-0.67 | $-0.63 | 22.8% | +18.8% | 0↑ 3↓ | $0.1B | 7.1% | 2 |
| Next FY 2027-12-31 |
$-0.43 | $-0.45 | $-0.41 | 33.9% | -38.7% | — | $0.1B | 11.3% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.190 | |
| 7d ago | $-0.200 | +0.010 |
| 30d ago | $-0.200 | +0.010 |
| 60d ago | $-0.200 | +0.010 |
| 90d ago | $-0.117 | -0.073 |
6 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 12, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 11, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 11, 2026 | Craig-Hallum | MAINTAIN | Buy | Buy |
| Mar 11, 2026 | Keybanc | MAINTAIN | Overweight | Overweight |
| Mar 10, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 24, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Feb 17, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 30, 2026 | B. Riley Securities | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| May 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Apr 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% | |
| Jan 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 27, 2026
short_volume
Short Volume: XGN — 61.6% short (0.3M / 0.5M)
Short: 329,404 | Exempt: 0 | TRF Vol: 534,594 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
May 11, 2026
earnings
Exagen Inc. Reports First Quarter 2026 Results
Delivers record total revenue and AVISE(R) CTD average selling price <pre>Delivers record total revenue and AVISE(R) CTD average selling price</pre>
May 11, 2026
earnings_calendar
XGN Q1 2026 Earnings Scheduled — 2026-05-11
May 4, 2026
earnings_calendar
XGN Q1 2026 Earnings Scheduled — 2026-05-04
Mar 10, 2026
earnings
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
<p align="center"><em>Record full-year total revenue and AVISE<sup>®</sup> CTD average selling price </em></p>
Mar 10, 2026
earnings_calendar
XGN Q4 2025 Earnings After Market Close — 2026-03-10